The organ allocation controversy: how did we arrive here?

Area of Science:

• Transplantation Medicine
• Health Policy
• Organ Donation

Background:

• The Department of Health and Human Services (HHS) introduced a new regulation for the Organ Procurement and Transplantation Network (OPTN).
• This regulation mandates organ allocation prioritizing the sickest patients, disregarding medical, geographic, and social factors previously considered essential by the transplant community.
• Current organ allocation policies are based on expert consensus, balancing patient need with efficient organ use, minimizing cold ischemic time, and supporting local donation initiatives.

Purpose of the Study:

• To evaluate the impact of the new HHS regulation on organ allocation policies.
• To assess the potential consequences of prioritizing the sickest patients over other allocation factors.
• To inform policy decisions regarding the future of organ procurement and transplantation.

Main Methods:

• Review of current organ allocation mechanisms and policies.
• Analysis of the implications of the new HHS regulation.
• Consideration of expert testimony and congressional actions, including a 1-year moratorium and an Institute of Medicine study.

Main Results:

• The new HHS rule prioritizes sickest patients, diverging from current policies that balance need with organ efficiency and local factors.
• Concerns exist within the transplant community that the new policy could lead to increased waste, reduced transplantation rates, higher death rates, and increased costs.
• Congress has responded with a moratorium and commissioned a study to investigate the existing policy and the new HHS regulation.

Conclusions:

• The HHS regulation represents a significant shift in organ allocation strategy.
• The potential benefits and drawbacks of prioritizing the sickest patients require thorough investigation.
• Further study is needed to determine the optimal organ allocation policy for the Organ Procurement and Transplantation Network.